Discover 1,171 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,171
Active & Responsive
The Congenital Dyserythropoietic Anemia Registry (CDAR)
for
Congenital Dyserythropoietic Anemia (CDA)
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 0+
Code: NCT02964494
Recruiting
Active & Responsive
Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders
for
Fragile X Syndrome, Autism Spectrum Disorder, Autistic Disorder,
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 5 - 10
Code: NCT06227780
Recruiting
Active & Responsive
A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study
Location: Cincinnati OH, Lexington KY, Ann Arbor MI,
Sponsor: Carelon Research
Sex: All
Age: 12 - 17
Code: NCT07525843
Recruiting
Active & Responsive
18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients
for
Tuberculosis, Pulmonary
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 18+
Code: NCT07077213
Recruiting
Active & Responsive
EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)
for
PIK3CA-related Overgrowth Spectrum (PROS)
Location: Cincinnati OH, Columbus OH, Pittsburgh PA, St Louis MO,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 2 - 70+
Code: NCT06997588
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
for
Hemophilia A
Location: Cincinnati OH, Indianapolis IN, Detroit MI, Chicago IL,
Sponsor: Wayne State University
Sex: All
Age: 6 - 19
Code: NCT05022459
Recruiting
Active & Responsive
Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
for
Pompe Disease
Location: Cincinnati OH, Pittsburgh PA, St Louis MO, Fairfax VA,
Sponsor: Shionogi
Sex: All
Age: 18+
Code: NCT07123155
Phase2, Recruiting
Active & Responsive
A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)
for
Cytomegalovirus Prophylaxis
Location: Cincinnati OH, Ann Arbor MI, Pittsburgh PA, Chicago IL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT07199465
Phase1, Recruiting
Active & Responsive
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
for
Peanut Allergy
Location: Cincinnati OH, Chapel Hill NC
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 12 - 55
Code: NCT07015996
Phase2, Recruiting
Active & Responsive
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
for
Fabry Disease
Location: Cincinnati OH, Fairfax VA, Iowa City IA, Atlanta GA,
Sponsor: Chiesi Farmaceutici S.p.A.
Sex: All
Age: 2 - 17
Code: NCT06328608
Phase2, Phase3, Recruiting
Active & Responsive
Clinical Course Of Disease In Participants With FA-CM
for
Friedreich Ataxia, Cardiomyopathy
Location: Cincinnati OH, Indianapolis IN, St Louis MO,
Sponsor: Lexeo Therapeutics
Sex: All
Age: 6+
Code: NCT06865482
Recruiting
Active & Responsive
Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy
Location: Cincinnati OH, Chicago IL, Nashville TN, Boston MA,
Sponsor: Fresenius Kabi
Sex: All
Age: 0 - 17
Code: NCT06274788
Recruiting
Active & Responsive
A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Anterior Vertebral Body Tethering
for
Scoliosis Idiopathic
Location: Cincinnati OH, Chicago IL, Nashville TN, Saint Louis MO,
Sponsor: Pediatric Spine Foundation
Sex: All
Age: 0 - 18
Code: NCT04914507
Recruiting
Active & Responsive
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Cincinnati OH, Indianapolis IN, Cleveland OH,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 2+
Code: NCT06789913
Phase2, Recruiting
Active & Responsive
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
for
Eosinophilic Gastrointestinal Disorders (EGIDs),
Location: Cincinnati OH, Chicago IL, Nashville TN, Bethesda MD,
Sponsor: Children's Hospital Medical Center, Cincinnati